Trial Details
TERMINATEDBasic Information
| Clinical ID | c4246 |
|---|---|
| Identifier | NCT00796250 |
| Trial Title | Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Infliximab|DRUG: AZA|DRUG: Placebo Prednisolone|DRUG: Prednisolone|DRUG: AZA|BIOLOGICAL: Placebo Infliximab |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2003-11-01 |
|---|---|
| Primary Completion Date | 2005-01-01 |
| Completion Date | 2005-01-01 |